ICON HOLDINGS CLINICAL RESEARCH INTERNATIONAL LIMITED

Icon Holdings Clinical Research International Limited (ICON) is a global contract research organisation that expands the possibilities of clinical research for sponsors, partners and patients. Drawing on deep expertise across therapeutic areas, ICON delivers end-to-end solutions that accelerate drug and device development, from early-phase bioanalytical work to late-stage market-access strategies.

The company's portfolio includes specialised services such as EngageAI - an AI-enhanced voice-of-the-customer platform - and bespoke blended solutions that address unique sponsor challenges. ICON also offers outcome-measure frameworks, comprehensive biotech outsourcing (including due-diligence and asset valuation), cardiac-safety monitoring, and a suite of site and patient solutions that prioritise patient-centric recruitment and real-time data capture. Its specialty-lab capabilities support precision-medicine programmes, while market-access experts guide pricing, reimbursement and regulatory pathways. In addition, ICON produces thought-leadership resources - whitepapers, surveys and webinars - on topics ranging from AI in software-as-a-medical-device to vaccine follow-up planning and the latest ICH GCP updates.

Through a combination of cutting-edge technology, data-driven insights and a collaborative approach, ICON helps biopharma, med-tech and academic partners bring innovative therapies to market more efficiently and safely.